ArticleCancer medicine2025

Avelumab + axitinib treatment in older patients with advanced renal cell carcinoma in Japan: Subgroup analyses of post-marketing surveillance data by age.

Mototsugu Oya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.